260 related articles for article (PubMed ID: 27779651)
41. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
[TBL] [Abstract][Full Text] [Related]
42. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
43. Cellular signals underlying β-adrenergic receptor mediated salivary gland enlargement.
Yeh CK; Chandrasekar B; Lin AL; Dang H; Kamat A; Zhu B; Katz MS
Differentiation; 2012 Jan; 83(1):68-76. PubMed ID: 22099178
[TBL] [Abstract][Full Text] [Related]
44. Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells.
Tutor AS; Penela P; Mayor F
Cardiovasc Res; 2007 Oct; 76(1):51-60. PubMed ID: 17628514
[TBL] [Abstract][Full Text] [Related]
45. Crosstalk of beta-adrenergic receptor subtypes through Gi blunts beta-adrenergic stimulation of L-type Ca2+ channels in canine heart failure.
He JQ; Balijepalli RC; Haworth RA; Kamp TJ
Circ Res; 2005 Sep; 97(6):566-73. PubMed ID: 16100050
[TBL] [Abstract][Full Text] [Related]
46. Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies.
Jahns R; Boivin V; Krapf T; Wallukat G; Boege F; Lohse MJ
J Am Coll Cardiol; 2000 Oct; 36(4):1280-7. PubMed ID: 11028484
[TBL] [Abstract][Full Text] [Related]
47. Coupling of beta-adrenergic receptors to cardiac L-type Ca2+ channels: preferential coupling of the beta1 versus beta2 receptor subtype and evidence for PKA-independent activation of the channel.
Yatani A; Tajima Y; Green SA
Cell Signal; 1999 May; 11(5):337-42. PubMed ID: 10376806
[TBL] [Abstract][Full Text] [Related]
48. Serum levels of sFas and sFasL during chemotherapy of lung cancer.
Naumnik W; Izycki T; Ossolinska M; Chyczewska E
Exp Oncol; 2007 Jun; 29(2):132-6. PubMed ID: 17704746
[TBL] [Abstract][Full Text] [Related]
49. The beta-adrenergic receptors.
Wallukat G
Herz; 2002 Nov; 27(7):683-90. PubMed ID: 12439640
[TBL] [Abstract][Full Text] [Related]
50. Gender related alterations of β-adrenoceptor mechanisms in heart failure due to arteriovenous fistula.
Dent MR; Tappia PS; Dhalla NS
J Cell Physiol; 2012 Aug; 227(8):3080-7. PubMed ID: 22015551
[TBL] [Abstract][Full Text] [Related]
51. β2-adrenoceptor transfection enhances contractile reserve of isolated rat ventricular myocytes exposed to chronic isoprenaline stimulation by improving β1-adrenoceptor responsiveness.
Jiang X; Xu C; Wang Y; Gao L; Yan C; Li D; Sun H
J Recept Signal Transduct Res; 2012 Feb; 32(1):36-41. PubMed ID: 22216755
[TBL] [Abstract][Full Text] [Related]
52. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
[TBL] [Abstract][Full Text] [Related]
53. Relationship between the autoantibody and expression of β3-adrenoceptor in lung and heart.
Miao G; Chen Z; Fang X; Liu M; Hao G; An H; Zhang Z; Lu L; Zhang J; Zhang L
PLoS One; 2013; 8(7):e68747. PubMed ID: 23861938
[TBL] [Abstract][Full Text] [Related]
54. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy.
Störk S; Boivin V; Horf R; Hein L; Lohse MJ; Angermann CE; Jahns R
Am Heart J; 2006 Oct; 152(4):697-704. PubMed ID: 16996841
[TBL] [Abstract][Full Text] [Related]
55. [Cardiovascular effects of beta1 and beta3-adrenergic receptor autoantibodies in Lewis rat].
Montaudon E; Abdelkrim MA; Desfontis JC; Mallem MY
Ann Cardiol Angeiol (Paris); 2014 Jun; 63(3):128-34. PubMed ID: 24861502
[TBL] [Abstract][Full Text] [Related]
56. Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure.
Rinaldi B; Capuano A; Gritti G; Donniacuo M; Scotto Di Vettimo A; Sodano L; Rafaniello C; Rossi F; Matera MG
Pulm Pharmacol Ther; 2014 Aug; 28(2):109-13. PubMed ID: 24769100
[TBL] [Abstract][Full Text] [Related]
57. Autoantibodies against the β3-adrenoceptor protect from cardiac dysfunction in a rat model of pressure overload.
Wang J; Li M; Ma X; Bai K; Wang L; Yan Z; Lv T; Zhao Z; Zhao R; Liu H
PLoS One; 2013; 8(10):e78207. PubMed ID: 24147120
[TBL] [Abstract][Full Text] [Related]
58. Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy.
Iwata M; Yoshikawa T; Baba A; Anzai T; Mitamura H; Ogawa S
J Am Coll Cardiol; 2001 Feb; 37(2):418-24. PubMed ID: 11216956
[TBL] [Abstract][Full Text] [Related]
59. β
Düngen HD; Dordevic A; Felix SB; Pieske B; Voors AA; McMurray JJV; Butler J
Circ Heart Fail; 2020 Jan; 13(1):e006155. PubMed ID: 31957469
[TBL] [Abstract][Full Text] [Related]
60. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
